Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer’s
Go back to Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer’s| Arbios Systems, Inc. (NASDAQ: ABOS) | Delayed: 3.10 +0.18 (6.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.92 | 52 Week High | $0.23 | |||
| Open | $2.93 | 52 Week Low | $0.00 | |||
| Day High | $3.11 | P/E | N/A | |||
| Day Low | $2.93 | EPS | $0.00 | |||
| Volume | 139,171 | |||||
